Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunoth...
Leadership
Harpreet Singh Ph.D.
CEO, MD, Member of Management Board & Executive Director
Venkat Ramanan Ph.D.
Chief Financial Officer
Amie Krause
Chief People Officer
Hans-Georg Rammensee Ph.D.Founder
Co-Founder & Member of the Scientific Advisory Board
